IDH1 and central nervous system cancer: These NL IDH-WT gliomas, which tend to occur in younger patients, bear fewer genomic mutations and alterations such as EGFR amplifications, chromosome 7/10 alterations, and TERT mutations although some would still qualify as diffuse astrocytic glioma with molecular features of glioblastoma (WHO grade IV).